|
|
Blood, 15 September 2004, Vol. 104, No. 6, pp. 1648-1655.
Prepublished online as a Blood First Edition Paper on June 3, 2004; DOI 10.1182/blood-2004-02-0448.
 Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity
David A. Hess,
Todd E. Meyerrose,
Louisa Wirthlin,
Timothy P. Craft,
Phillip E. Herrbrich,
Michael H. Creer, and
Jan A. Nolta
From the Department of Internal Medicine, Division of Oncology, Hematopoietic Development and Malignancy Program, Washington University School of Medicine, St Louis, MO; and the Departments of Pathology and Laboratory Medicine, Saint Louis University School of Medicine, St Louis, MO.
Human hematopoietic stem cells (HSCs) are commonly purified by the expression of cell surface markers such as CD34. Because cell phenotype can be altered by cell cycle progression or ex vivo culture, purification on the basis of conserved stem cell function may represent a more reliable way to isolate various stem cell populations. We have purified primitive HSCs from human umbilical cord blood (UCB) by lineage depletion (Lin-) followed by selection of cells with high aldehyde dehydrogenase (ALDH) activity. ALDHhiLin- cells contained 22.6% ± 3.0% of the Lin- population and highly coexpressed primitive HSC phenotypes (CD34+ CD38- and CD34+CD133+). In vitro hematopoietic progenitor function was enriched in the ALDHhiLin- population, compared with ALDHloLin- cells. Multilineage human hematopoietic repopulation was observed exclusively after transplantation of ALDHhiLin- cells. Direct comparison of repopulation with use of the nonobese diabetic/severe combined immunodeficient (NOD/SCID) and NOD/SCID  2 microglobulin (2M) null models demonstrated that 10-fold greater numbers of ALDHhi-Lin- cells were needed to engraft the NOD/SCID mouse as compared with the more permissive NOD/SCID 2M null mouse, suggesting that the ALDHhiLin- population contained committed progenitors as well as primitive repopulating cells. Cell fractionation according to lineage depletion and ALDH activity provides a viable and prospective purification of HSCs on the basis of cell function rather than cell surface phenotype. (Blood. 2004;104:1648-1655)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
Vitamin A metabolism and stemness
- Edward F. Srour
Blood 2004 104: 1597-1598.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
S. Ahmad, S. Kolli, D.-Q. Li, C. S. de Paiva, S. Pryzborski, I. Dimmick, L. Armstrong, F. C. Figueiredo, and M. Lako
A Putative Role for RHAMM/HMMR as a Negative Marker of Stem Cell-Containing Population of Human Limbal Epithelial Cells
Stem Cells,
June 1, 2008;
26(6):
1609 - 1619.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Hess, T. P. Craft, L. Wirthlin, S. Hohm, P. Zhou, W. C. Eades, M. H. Creer, M. S. Sands, and J. A. Nolta
Widespread Nonhematopoietic Tissue Distribution by Transplanted Human Progenitor Cells with High Aldehyde Dehydrogenase Activity
Stem Cells,
March 1, 2008;
26(3):
611 - 620.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Maxwell, J. Bonde, D. A. Hess, S. A. Hohm, R. Lahey, P. Zhou, M. H. Creer, D. Piwnica-Worms, and J. A. Nolta
Fluorophore-Conjugated Iron Oxide Nanoparticle Labeling and Analysis of Engrafting Human Hematopoietic Stem Cells
Stem Cells,
February 1, 2008;
26(2):
517 - 524.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. J. Povsic, K. L. Zavodni, F. L. Kelly, S. Zhu, P. J. Goldschmidt-Clermont, C. Dong, and E. D. Peterson
Circulating Progenitor Cells Can Be Reliably Identified on the Basis of Aldehyde Dehydrogenase Activity
J. Am. Coll. Cardiol.,
December 4, 2007;
50(23):
2243 - 2248.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Luo, A. Wang, K. J. Payne, H. Peng, J.-g. Wang, Y. K. Parrish, J. W. Rogerio, T. J. Triche, Q. He, and L. Wu
Intrinsic Retinoic Acid Receptor {alpha}-Cyclin-Dependent Kinase-Activating Kinase Signaling Involves Coordination of the Restricted Proliferation and Granulocytic Differentiation of Human Hematopoietic Stem Cells
Stem Cells,
October 1, 2007;
25(10):
2628 - 2637.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Christ, K. Lucke, S. Imren, K. Leung, M. Hamilton, A. Eaves, C. Smith, and C. Eaves
Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity
Haematologica,
September 1, 2007;
92(9):
1165 - 1172.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Nagano, T. Yamashita, H. Hamada, K. Ohneda, K.-i. Kimura, T. Nakagawa, M. Shibuya, H. Yoshikawa, and O. Ohneda
Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood
Blood,
July 1, 2007;
110(1):
151 - 160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Feldmann, S. Dhara, V. Fendrich, D. Bedja, R. Beaty, M. Mullendore, C. Karikari, H. Alvarez, C. Iacobuzio-Donahue, A. Jimeno, et al.
Blockade of Hedgehog Signaling Inhibits Pancreatic Cancer Invasion and Metastases: A New Paradigm for Combination Therapy in Solid Cancers
Cancer Res.,
March 1, 2007;
67(5):
2187 - 2196.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. Chute, G. G. Muramoto, J. Whitesides, M. Colvin, R. Safi, N. J. Chao, and D. P. McDonnell
Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells
PNAS,
August 1, 2006;
103(31):
11707 - 11712.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. P. Marshall II, E. D. Laywell, T. Zheng, D. A. Steindler, and E. W. Scott
In Vitro-Derived "Neural Stem Cells" Function as Neural Progenitors Without the Capacity for Self-Renewal
Stem Cells,
March 1, 2006;
24(3):
731 - 738.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Hess, L. Wirthlin, T. P. Craft, P. E. Herrbrich, S. A. Hohm, R. Lahey, W. C. Eades, M. H. Creer, and J. A. Nolta
Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells
Blood,
March 1, 2006;
107(5):
2162 - 2169.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Corti, F. Locatelli, D. Papadimitriou, C. Donadoni, R. Del Bo, M. Crimi, A. Bordoni, F. Fortunato, S. Strazzer, G. Menozzi, et al.
Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1
Hum. Mol. Genet.,
January 15, 2006;
15(2):
167 - 187.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Ravandi and Z. Estrov
Eradication of Leukemia Stem Cells as a New Goal of Therapy in Leukemia
Clin. Cancer Res.,
January 15, 2006;
12(2):
340 - 344.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Locke, M. Heywood, S. Fawell, and I. C. Mackenzie
Retention of Intrinsic Stem Cell Hierarchies in Carcinoma-Derived Cell Lines
Cancer Res.,
October 1, 2005;
65(19):
8944 - 8950.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. W. Storms, P. D. Green, K. M. Safford, D. Niedzwiecki, C. R. Cogle, O. M. Colvin, N. J. Chao, H. E. Rice, and C. A. Smith
Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34
Blood,
July 1, 2005;
106(1):
95 - 102.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Pearce, D. Taussig, C. Simpson, K. Allen, A. Z. Rohatiner, T. A. Lister, and D. Bonnet
Characterization of Cells with a High Aldehyde Dehydrogenase Activity from Cord Blood and Acute Myeloid Leukemia Samples
Stem Cells,
June 1, 2005;
23(6):
752 - 760.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Vodyanik, J. A. Bork, J. A. Thomson, and I. I. Slukvin
Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential
Blood,
January 15, 2005;
105(2):
617 - 626.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
